Publications by authors named "Line Schmidt Tarpgaard"

Claim this Profile
N
New dosing schedules in pre-treated patients with metastatic colorectal cancer.
Per Pfeiffer, Line Schmidt Tarpgaard

J Gastrointest Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.
Susy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, Per Pfeiffer, Line Schmidt Tarpgaard

Invest New Drugs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial.
Ismail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, Mustafa Bulut, Torben Frøstrup Hansen

Ann Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Ingrid Terese Foslund, Sahra Aisha Vinholt von Magius, Alan Patrick Ainsworth, Sönke Detlefsen, Claus Wilki Fristrup, Line Schmidt Tarpgaard

Pleura Peritoneum· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies.
Line Schmidt Tarpgaard, Stine Brændegaard Winther, Per Pfeiffer

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol.
Tobias Freyberg Justesen, Ismail Gögenur, Line Schmidt Tarpgaard, Per Pfeiffer, Camilla Qvortrup

BMJ Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.
Jesper Andreas Palshof, Estrid Vilma Solyom Høgdall, Tim Svenstrup Poulsen, Dorte Linnemann, Benny Vittrup Jensen, Line Schmidt Tarpgaard

BMC Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
Mads Heilskov Rasmussen, Iben Lyskjær, Rosa Rakownikow Jersie-Christensen, Line Schmidt Tarpgaard, Bjarke Primdal-Bengtson

Nat Commun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis